Morgan Lewis Advises Russia-China Investment Fund on Creation of Large Russian Pharma Holding Company

MOSCOW, February 19, 2021: Morgan Lewis represented a consortium of investors led by the Russia-China Investment Fund (RCIF), which was established by the Russian Direct Investment Fund and China Investment Corporation, on the establishment and joint development of Binnopharm Group, a pharmaceutical holding company created on the basis of JSC Alium and OJSC Sintez.

As a result, Binnopharm Group, which also includes Sistema PJFSC, a publicly traded Russian investment company, and VTB Group, a leading Russian banking group, will become one of the three largest pharmaceutical manufacturers in Russia as part of a long-term strategy to consolidate the Russian pharmaceutical market and create a leading producer of medicines and innovative pharmaceuticals.

Partner Artem Tamaev and associates Emil Shagiakhmetov, Valentina Semenikhina, Philip Korotin, Anastasia Kiseleva, and Andrey Ignatenko.

For more, read the RCIF’s announcement.